WHWK
NASDAQ
US
Whitehawk Therapeutics, Inc. - Common Stock
$3.51
▼ $-0.03
(-0.85%)
Vol 95K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$114.1M
ROE
-10.4%
Margin
99.4%
D/E
0.00
Beta
0.63
52W
$1–$4
Wall Street Consensus
11 analysts · Apr 20263
Strong Buy
4
Buy
4
Hold
0
Sell
0
Strong Sell
63.6%
Buy Rating
Price Chart
Similar Stocks
CNTN
Canton Strategic Holdings Inc
CNTB
Connect Biopharma Holdings Ltd
$157.6M
PRLD
Prelude Therapeutics Inc
$164.2M
ARTV
Artiva Biotherapeutics Inc
$105.3M
RNAC
Cartesian Therapeutics Inc
$187.5M
NKTX
Nkarta Inc
$131.4M
ABOS
Acumen Pharmaceuticals Inc
$127.8M
VTVT
vTv Therapeutics Inc
$167.1M
KALA
KALA BIO Inc
$12.2M
IMUX
Immunic Inc
$64.2M
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.16 | $-0.34 | $-0.18 |
| Sep 2025 | $0.07 | $-0.26 | $-0.33 |
| Jun 2025 | $0.50 | $-0.76 | $-1.26 |
| Mar 2025 | $-0.47 | $-0.37 | +$0.10 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -8.1% | -8.1% | -8.1% | -8.1% | -10.3% | -10.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | 99.4% | 99.4% | 99.4% | 99.4% | 99.4% |
| Gross Margin | — | 88.7% | 88.7% | 88.7% | 88.7% | 88.7% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 20.41 | 20.41 | 20.41 | 20.41 | 16.76 | 16.76 |
Key Ratios
ROA (TTM)
-9.6%
P/S (TTM)
4.11
EPS (TTM)
$0.14
Rev Growth 3Y
+185.2%
52W High
$3.81
52W Low
$1.39
$1.39
52-Week Range
$3.81
How does WHWK compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
WHWK valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
4.1
▼
68%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
WHWK profitability vs Biotechnology peers
ROE
-10.4%
▲
85%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
99.4%
▲
135%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
88.7%
▲
13%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-9.6%
▲
79%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
WHWK financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
16.8
▲
277%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.6
▼
35%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
WHWK fundamentals radar
WHWK
Peer median
Industry
WHWK profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
WHWK vs peers: key metrics
Latest News
No related news yet